Volume 126, Issue 3, Pages (March 2004)

Slides:



Advertisements
Similar presentations
Volume 32, Issue 9, Pages (September 2012)
Advertisements

Hepatitis C and Alcohol Exacerbate Liver Injury by Suppression of FOXO3  Batbayar Tumurbaatar, Irina Tikhanovich, Zhuan Li, Jinyu Ren, Robert Ralston,
Volume 125, Issue 1, Pages (July 2003)
Volume 127, Issue 6, Pages (December 2004)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 125, Issue 1, Pages (July 2003)
Volume 132, Issue 5, Pages (May 2007)
Volume 132, Issue 3, Pages (March 2007)
Volume 138, Issue 1, Pages (January 2010)
Volume 136, Issue 1, Pages e2 (January 2009)
Volume 115, Issue 6, Pages (December 1998)
Volume 132, Issue 3, Pages (March 2007)
C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice  Belinda Knight, Janina E.E. Tirnitz–Parker,
Volume 127, Issue 4, Pages (October 2004)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 127, Issue 5, Pages (November 2004)
Volume 41, Issue 2, Pages (August 2004)
Volume 125, Issue 6, Pages (December 2003)
Reduced Expression of Ferroportin-1 Mediates Hyporesponsiveness of Suckling Rats to Stimuli That Reduce Iron Absorption  Deepak Darshan, Sarah J. Wilkins,
Volume 133, Issue 6, Pages (December 2007)
Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. (A–C)
Volume 64, Issue 1, Pages (January 2016)
Volume 118, Issue 4, Pages (April 2000)
Volume 137, Issue 4, Pages e5 (October 2009)
MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity 
Volume 128, Issue 5, Pages (May 2005)
Volume 129, Issue 5, Pages (November 2005)
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 135, Issue 5, Pages (November 2008)
Volume 126, Issue 5, Pages (May 2004)
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 42, Issue 4, Pages (April 2005)
Volume 127, Issue 6, Pages (December 2004)
Volume 6, Issue 3, Pages (September 2007)
Volume 132, Issue 1, Pages (January 2007)
Volume 139, Issue 1, Pages e6 (July 2010)
Volume 122, Issue 4, Pages (April 2002)
Volume 7, Issue 3, Pages (March 2008)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 136, Issue 7, Pages (June 2009)
Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis 
Volume 127, Issue 4, Pages (October 2004)
Volume 64, Issue 4, Pages (October 2003)
Volume 39, Issue 4, Pages (October 2003)
Volume 143, Issue 1, Pages e7 (July 2012)
T Cell-Derived Lymphotoxin Regulates Liver Regeneration
Role of Connective Tissue Growth Factor in Oval Cell Response During Liver Regeneration After 2-AAF/PHx in Rats  Liya Pi, Seh-Hoon Oh, Thomas Shupe, Bryon.
Volume 125, Issue 6, Pages (December 2003)
Volume 134, Issue 4, Pages (April 2008)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 139, Issue 2, Pages e1 (August 2010)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 132, Issue 3, Pages (March 2007)
Volume 125, Issue 1, Pages (July 2003)
Volume 130, Issue 7, Pages (June 2006)
Volume 133, Issue 4, Pages (October 2007)
Volume 135, Issue 4, Pages (October 2008)
Volume 137, Issue 4, Pages (October 2009)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
Volume 14, Issue 1, Pages (July 2011)
Volume 19, Issue 5, Pages (November 2003)
Volume 144, Issue 5, Pages e4 (May 2013)
Volume 3, Issue 2, Pages (February 2006)
Amphiregulin: An early trigger of liver regeneration in mice
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Covering the Cover Gastroenterology
MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity 
Volume 55, Issue 2, Pages (February 1999)
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Presentation transcript:

Volume 126, Issue 3, Pages 873-885 (March 2004) Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met  Kengo Tomita, Toshifumi Azuma, Naoto Kitamura, Jiro Nishida, Gen Tamiya, Akira Oka, Sayaka Inokuchi, Takeshi Nishimura, Makoto Suematsu, Hiromasa Ishii  Gastroenterology  Volume 126, Issue 3, Pages 873-885 (March 2004) DOI: 10.1053/j.gastro.2003.12.008

Figure 1 Effect of pioglitazone on liver histology in the ethanol-fed rats. (A) H&E-stained sections of representative liver samples of control rats (Cont), ethanol-fed rats (EtOH), and ethanol-fed rats given pioglitazone (EtOH+Piog) (×40). Minimal steatosis or no change was seen in the livers of the pair-fed control rats. Severe macrovesicular steatosis was observed preferentially in the perivenular areas in the ethanol-fed rats. Pioglitazone markedly decreased accumulation of lipid droplets in both the perivenular and the periportal areas. Only minimal steatosis was left in the livers of ethanol-fed rats given pioglitazone. (B) Oil red-stained sections of representative liver samples of control rats, ethanol-fed rats, and ethanol-fed rats given pioglitazone (×40). Specific staining of lipid accumulation was shown. Pioglitazone markedly decreased accumulation of lipid droplets. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)

Figure 2 Hepatic c-Met, HGF, and apoB expression. (A) DNA microarray analysis showed that pioglitazone increased hepatic c-Met mRNA expression. Results (and standard error of the mean) from 3 rats/group at the end of feeding period. aP < 0.05 versus the ethanol-fed group. EtOH, ethanol-fed rats; PIO+EtOH, ethanol-fed rats given pioglitazone. (B) Real-time PCR analysis showed that chronic ethanol feeding decreased hepatic c-Met expression and that pioglitazone prevented this decrease. Results (and standard error of the mean) from 6 rats/group at the end of feeding period. All real-time quantitative PCR reactions were carried out in duplicate. aP < 0.05 versus the ethanol-fed group. (C) Western immunoblot analysis of expression of c-Met (upper) and tyrosine phosphorylation of c-Met (lower) in liver homogenates (containing 50 μg of total protein each). (D) Real-time PCR analysis (upper) and Western blotting analysis (lower) showed that chronic ethanol feeding increased hepatic HGF expression and pioglitazone had no effect on this. Results (and standard error of the mean) from 6 rats/group at the end of feeding period. All real-time quantitative PCR reactions were carried out in duplicate. bP < 0.05 versus the control group. (E) Western immunoblot analysis of expression of apoB in liver homogenates (containing 50 μg of total protein each). Control, rats pair-fed isocaloric liquid diet without ethanol; EtOH, ethanol-fed rats; PIO+EtOH, ethanol-fed rats given pioglitazone. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)

Figure 3 Direct effect of pioglitazone on expression and tyrosine phosphorylation of c-Met, expression of apoB, and on DNA synthesis in rat primary cultured hepatocytes. (A) Rat primary-cultured hepatocytes were incubated with various doses of pioglitazone or troglitazone for 24 hours (from 24 to 48 hours after inoculation). In the control, the medium was supplemented with the same volume of DMSO. Real-time quantitative PCR analysis of c-Met showed that 10 μmol/L of pioglitazone treatment dramatically increased c-Met expression. Ten μmol/L of troglitazone treatment also significantly increased c-Met expression. Addition of 300 μmol/L of BADGE inhibited this increase. All real-time quantitative PCR reactions were carried out in duplicate. Results (and standard error of the mean) from 4 individual experiments. aP < 0.05 versus the groups with 0 or 1 μmol/L of pioglitazone or troglitazone treatment. (B) Tyrosine phosphorylation of c-Met in homogenates of primary-cultured hepatocytes stimulated or not with 5 ng/mL HGF or pioglitazone. Addition of 10 μmol/L pioglitazone induced tyrosine phosphorylation of c-Met. (C) Effect of pioglitazone on DNA synthesis of primary cultured hepatocytes. BrdU incorporation into cellular DNA was determined 24 hours after the addition of HGF and/or pioglitazone. aP < 0.05 versus the other groups. bP < 0.05 versus the groups without any addition of HGF or pioglitazone. Next, real-time PCR analysis of primary-cultured hepatocytes was used to assess apoB gene expression (D, E). (D) Rat primary-cultured hepatocytes were incubated with various doses of HGF for 24 hours. aP < 0.05 versus the group without addition of HGF. (E) Incubation with pioglitazone with addition of 5 ng/mL of HGF for 24 hours. bP < 0.05 versus the group without any addition of pioglitazone. All real-time quantitative PCR reactions were carried out in duplicate. Results (and standard error of the mean) from 4 individual experiments. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)

Figure 4 Troglitazone mimicked the actions of pioglitazone in vivo. Eight-week-old male SD rats fed ethanol-containing liquid diet were given troglitazone (200 mg/kg body weight per day) once every 24 hours intragastrically for 6 weeks. In this study, we divided the rats into 3 groups in the same way as our last examination of pioglitazone (n = 6). Troglitazone decreased accumulation of lipid droplets and suppressed the elevation of serum concentrations of ALT in ethanol-fed rats. Real-time PCR analyses showed that ethanol administration decreased hepatic c-Met expression and that troglitazone prevented this decrease. Results (and standard error of the mean) from 6 rats/group at the end of feeding period. All real-time quantitative PCR reactions were carried out in duplicate. aP < 0.05 versus the other groups. bP < 0.05 versus the ethanol-fed group. Control, rats pair-fed isocaloric liquid diet without ethanol; EtOH, ethanol-fed rats; TRO+EtOH, ethanol-fed rats given troglitazone. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)

Figure 5 Hepatic SCD1, SCD2, SREBP-1a, and SREBP-1c expression. Real-time PCR analysis was carried out to quantitate hepatic mRNA levels of SCD1, SCD2, SREBP-1a, and SREBP-1c in liver homogenates among the groups. Results (and standard error of the mean) from 4 rats/group at the end of feeding period. All real-time quantitative PCR reactions were carried out in duplicate. aP < 0.05 versus the other groups. bP < 0.05 versus the ethanol-fed group. Control, rats pair-fed isocaloric liquid diet without ethanol; EtOH, ethanol-fed rats; PIO+EtOH, ethanol-fed rats given pioglitazone. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)

Figure 6 Effects of pioglitazone and HGF on expression of SREBP-1a, c, and SCD-1, 2 mRNA in hepatocyte cultures. Real-time PCR analysis was used to assess SREBP-1a, SREBP-1c, SCD-1, and SCD-2 gene expression. (A) Rat primary-cultured hepatocytes were incubated with various doses of HGF for 24 hours. aP < 0.05 versus the other groups. bP < 0.05 versus the group with addition of 10 ng/mL of HGF. (B) Incubation with pioglitazone with addition of 5 ng/mL of HGF for 24 hours. cP < 0.05 versus the group without any addition of pioglitazone. (C) Incubation with various doses of pioglitazone for 24 hours. All real-time quantitative PCR reactions were carried out in duplicate. Results (and standard error of the mean) from 4 individual experiments. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)

Figure 7 Effect of pioglitazone on hepatic lipid peroxidation, apoptosis, and expression of stress response proteins. (A) Immunohistochemistry for 4-HNE. Representative liver samples of control rat (Cont), ethanol-fed rats (EtOH), and ethanol-fed rats given pioglitazone (EtOH+Piog) (×100). (B) Real-time PCR analysis was used to assess stress response proteins such as MT-1, MT-2, and HOX-1 mRNA expression in liver homogenates among the groups. Results (and standard error of the mean) from 4 rats/group at the end of feeding period. All real-time quantitative PCR reactions were carried out in duplicate. aP < 0.05 versus the other groups. (C) TUNEL results of liver apoptosis among the treated groups. The apoptotic cells and hepatocytes were counted from 5 lower microscopic fields for each animal. Gastroenterology 2004 126, 873-885DOI: (10.1053/j.gastro.2003.12.008)